3,980 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2314699/procept-biorobotics-corporation-prct-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2314699 Aug 01, 2024 - PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of 3.85% and 6.08%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Clipper Realty Inc. (CLPR) Tops Q2 FFO and Revenue Estimates https://www.zacks.com/stock/news/2314708/clipper-realty-inc-clpr-tops-q2-ffo-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2314708 Aug 01, 2024 - Clipper Realty (CLPR) delivered FFO and revenue surprises of 70% and 4.32%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Regenxbio (RGNX) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2314680/regenxbio-rgnx-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2314680 Aug 01, 2024 - Regenxbio (RGNX) delivered earnings and revenue surprises of 18.60% and 2.59%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Arteris, Inc. (AIP) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2314687/arteris-inc-aip-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2314687 Aug 01, 2024 - Arteris (AIP) delivered earnings and revenue surprises of 26.67% and 6.58%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2314688/ardelyx-ardx-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2314688 Aug 01, 2024 - Ardelyx (ARDX) delivered earnings and revenue surprises of 30% and 31.38%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Travere Therapeutics (TVTX) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2314655/travere-therapeutics-tvtx-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2314655 Aug 01, 2024 - Travere (TVTX) delivered earnings and revenue surprises of -3.45% and 9.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Aaon (AAON) Tops Q2 Earnings and Revenue Estimates https://www.zacks.com/stock/news/2314656/aaon-aaon-tops-q2-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2314656 Aug 01, 2024 - Aaon (AAON) delivered earnings and revenue surprises of 14.81% and 9.88%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Alignment Healthcare (ALHC) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2314657/alignment-healthcare-alhc-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2314657 Aug 01, 2024 - Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 7.14% and 7.66%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Upland Software (UPLD) Tops Q2 Earnings and Revenue Estimates https://www.zacks.com/stock/news/2314647/upland-software-upld-tops-q2-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2314647 Aug 01, 2024 - Upland Software (UPLD) delivered earnings and revenue surprises of 26.67% and 2.11%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Ultragenyx (RARE) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2314646/ultragenyx-rare-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2314646 Aug 01, 2024 - Ultragenyx (RARE) delivered earnings and revenue surprises of 7.32% and 19.13%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
<<<Page 99>